286 related articles for article (PubMed ID: 24804831)
1. Salivary duct carcinoma and the concept of early carcinoma ex pleomorphic adenoma.
Griffith CC; Thompson LD; Assaad A; Purgina BM; Lai C; Bauman JE; Weinreb I; Seethala RR; Chiosea SI
Histopathology; 2014 Dec; 65(6):854-60. PubMed ID: 24804831
[TBL] [Abstract][Full Text] [Related]
2. Immunohistochemical expression of mammaglobin in salivary duct carcinomas de novo and salivary duct carcinoma ex pleomorphic adenoma.
Soares CD; de Lima Morais TM; Carlos R; Martins MD; de Almeida OP; Mariano FV; Altemani A
Hum Pathol; 2019 Oct; 92():59-66. PubMed ID: 31400353
[TBL] [Abstract][Full Text] [Related]
3. Carcinoma ex pleomorphic adenoma with special reference to the prognostic significance of histological progression: a clinicopathological investigation of 41 cases.
Weiler C; Zengel P; van der Wal JE; Guntinas-Lichius O; Schwarz S; Harrison JD; Kirchner T; Ihrler S
Histopathology; 2011 Oct; 59(4):741-50. PubMed ID: 22014054
[TBL] [Abstract][Full Text] [Related]
4. A 20-Year Review of 75 Cases of Salivary Duct Carcinoma.
Gilbert MR; Sharma A; Schmitt NC; Johnson JT; Ferris RL; Duvvuri U; Kim S
JAMA Otolaryngol Head Neck Surg; 2016 May; 142(5):489-95. PubMed ID: 26939990
[TBL] [Abstract][Full Text] [Related]
5. Prognostic factors of recurrence in salivary carcinoma ex pleomorphic adenoma, with emphasis on the carcinoma histologic subtype: a clinicopathologic study of 43 cases.
Katabi N; Gomez D; Klimstra DS; Carlson DL; Lee N; Ghossein R
Hum Pathol; 2010 Jul; 41(7):927-34. PubMed ID: 20338616
[TBL] [Abstract][Full Text] [Related]
6. An analysis of PLAG1 and HMGA2 rearrangements in salivary duct carcinoma and examination of the role of precursor lesions.
Bahrami A; Perez-Ordonez B; Dalton JD; Weinreb I
Histopathology; 2013 Aug; 63(2):250-62. PubMed ID: 23738717
[TBL] [Abstract][Full Text] [Related]
7. Prognostic factors of carcinoma ex pleomorphic adenoma of the salivary glands, with emphasis on the widely invasive carcinoma: a clinicopathologic analysis of 361 cases in a Chinese population.
Hu YH; Zhang CY; Xia RH; Tian Z; Wang LZ; Li J
Oral Surg Oral Med Oral Pathol Oral Radiol; 2016 Nov; 122(5):598-608. PubMed ID: 27546212
[TBL] [Abstract][Full Text] [Related]
8. Increased SOX2 expression in salivary gland carcinoma ex pleomorphic adenoma progression: an association with adverse outcome.
Sedassari BT; Rodrigues MFSD; Conceição TS; Mariano FV; Alves VAF; Nunes FD; Altemani A; de Sousa SCOM
Virchows Arch; 2017 Dec; 471(6):775-784. PubMed ID: 28842747
[TBL] [Abstract][Full Text] [Related]
9. [Carcinoma ex pleomorphic adenoma of major salivary glands--a clinicopathologic review].
Stodulski D; Rzepko R; Kowalska B; Stankiewicz C
Otolaryngol Pol; 2007; 61(5):687-93. PubMed ID: 18552001
[TBL] [Abstract][Full Text] [Related]
10. Differential expression of TRKB tyrosine kinase in the two histological types of parotid salivary duct carcinoma with cancer aggressiveness.
Moriwaki K; Ayani Y; Kuwabara H; Terada T; Higashino M; Kawata R
Oral Oncol; 2024 Apr; 151():106751. PubMed ID: 38479153
[TBL] [Abstract][Full Text] [Related]
11. Carcinoma ex pleomorphic adenoma: pathologic analysis of 73 cases.
Lewis JE; Olsen KD; Sebo TJ
Hum Pathol; 2001 Jun; 32(6):596-604. PubMed ID: 11431714
[TBL] [Abstract][Full Text] [Related]
12. Sarcomatoid variant of salivary duct carcinoma: clinicopathologic and immunohistochemical study of eight cases with review of the literature.
Nagao T; Gaffey TA; Serizawa H; Iwaya K; Watanabe A; Yoshida T; Yamazaki K; Sageshima M; Lewis JE
Am J Clin Pathol; 2004 Aug; 122(2):222-31. PubMed ID: 15323139
[TBL] [Abstract][Full Text] [Related]
13. An intracapsular carcinoma ex pleomorphic adenoma with lung metastases composed exclusively of benign elements: histological evidence of a continuum between metastasizing pleomorphic adenoma and carcinoma ex pleomorphic adenoma.
Weissferdt A; Langman G
Pathol Res Pract; 2010 Jul; 206(7):480-3. PubMed ID: 19665316
[TBL] [Abstract][Full Text] [Related]
14. Non-invasive (intracapsular) carcinoma ex pleomorphic adenoma: recognition of focal carcinoma by HER-2/neu and MIB1 immunohistochemistry.
Di Palma S; Skálová A; Vanìèek T; Simpson RH; Stárek I; Leivo I
Histopathology; 2005 Feb; 46(2):144-52. PubMed ID: 15693886
[TBL] [Abstract][Full Text] [Related]
15. Clinicopathological effect of PLAG1 fusion genes in pleomorphic adenoma and carcinoma ex pleomorphic adenoma with special emphasis on histological features.
Asahina M; Saito T; Hayashi T; Fukumura Y; Mitani K; Yao T
Histopathology; 2019 Feb; 74(3):514-525. PubMed ID: 30307055
[TBL] [Abstract][Full Text] [Related]
16. Carcinoma ex-pleomorphic adenoma of the salivary glands has a high risk of progression when the tumor invades more than 2.5 mm beyond the capsule of the residual pleomorphic adenoma.
Rito M; Fonseca I
Virchows Arch; 2016 Mar; 468(3):297-303. PubMed ID: 26638158
[TBL] [Abstract][Full Text] [Related]
17. Salivary duct carcinoma ex pleomorphic adenoma: analysis of the findings in fine-needle aspiration cytology and histology.
Ersöz C; Cetik F; Aydin O; Cosar EF; Talas DU
Diagn Cytopathol; 1998 Sep; 19(3):201-4. PubMed ID: 9740996
[TBL] [Abstract][Full Text] [Related]
18. Carcinoma ex pleomorphic adenoma of the buccal region is composed of salivary duct carcinoma and squamous cell carcinoma components.
Nakamori K; Ohuchi T; Hasegawa T; Hiratsuka H
Int J Oral Maxillofac Surg; 2009 Oct; 38(10):1116-8. PubMed ID: 19467841
[TBL] [Abstract][Full Text] [Related]
19. Clear cell myoepithelial carcinoma of salivary glands showing EWSR1 rearrangement: molecular analysis of 94 salivary gland carcinomas with prominent clear cell component.
Skálová A; Weinreb I; Hyrcza M; Simpson RH; Laco J; Agaimy A; Vazmitel M; Majewska H; Vanecek T; Talarčik P; Manajlovic S; Losito SN; Šteiner P; Klimkova A; Michal M
Am J Surg Pathol; 2015 Mar; 39(3):338-48. PubMed ID: 25581728
[TBL] [Abstract][Full Text] [Related]
20. Carcinoma ex pleomorphic adenoma of the parotid gland: a multi-institutional retrospective analysis in the Northern Japan Head and Neck Cancer Society.
Suzuki M; Matsuzuka T; Saijo S; Takahara M; Harabuchi Y; Okuni T; Himi T; Kakizaki T; Fukuda S; Yamada K; Nagahashi T; Abe T; Shinkawa H; Katagiri K; Sato H; Fukui N; Ishikawa K; Suzuki T; Kobayashi T; Saito D; Saijo S; Tateda M; Hashimoto S; Ishida A; Kakehata S; Suzuki O; Hashimoto Y; Omori K
Acta Otolaryngol; 2016 Nov; 136(11):1154-1158. PubMed ID: 27295405
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
